| __timestamp | Amneal Pharmaceuticals, Inc. | ImmunityBio, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 106735000 | 1595000 |
| Thursday, January 1, 2015 | 136870000 | 11434000 |
| Friday, January 1, 2016 | 204747000 | 26546000 |
| Sunday, January 1, 2017 | 191938000 | 39778000 |
| Monday, January 1, 2018 | 210451000 | 53418000 |
| Tuesday, January 1, 2019 | 202287000 | 111997000 |
| Wednesday, January 1, 2020 | 190585000 | 139507000 |
| Friday, January 1, 2021 | 209563000 | 195958000 |
| Saturday, January 1, 2022 | 200046000 | 248149000 |
| Sunday, January 1, 2023 | 167778000 | 232366000 |
Unlocking the unknown
In the ever-evolving landscape of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Amneal Pharmaceuticals, Inc. and ImmunityBio, Inc. have demonstrated contrasting trajectories in their R&D investments.
Amneal Pharmaceuticals has consistently invested in R&D, with expenditures peaking in 2018 at approximately 21% higher than in 2014. However, a slight decline was observed in 2023, with a 20% reduction from its 2018 peak. This trend reflects a strategic shift or market adaptation.
Conversely, ImmunityBio, Inc. has shown a remarkable upward trend, with R&D spending skyrocketing by over 14,500% from 2014 to 2023. This surge underscores their commitment to pioneering breakthroughs, particularly in immunotherapy.
These trends highlight the dynamic nature of pharmaceutical R&D, where strategic investments can lead to groundbreaking advancements.
AstraZeneca PLC vs ImmunityBio, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Novartis AG vs Amneal Pharmaceuticals, Inc.
Bristol-Myers Squibb Company or Amneal Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Genmab A/S vs Amneal Pharmaceuticals, Inc.
Analyzing R&D Budgets: Grifols, S.A. vs Amneal Pharmaceuticals, Inc.
Research and Development Investment: Alpine Immune Sciences, Inc. vs ImmunityBio, Inc.
Amneal Pharmaceuticals, Inc. or Ultragenyx Pharmaceutical Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Amneal Pharmaceuticals, Inc. vs Geron Corporation
R&D Insights: How Amneal Pharmaceuticals, Inc. and Dynavax Technologies Corporation Allocate Funds
Analyzing R&D Budgets: Amneal Pharmaceuticals, Inc. vs Galapagos NV
R&D Spending Showdown: CymaBay Therapeutics, Inc. vs ImmunityBio, Inc.
Comparing Innovation Spending: Xenon Pharmaceuticals Inc. and ImmunityBio, Inc.